It’s hard to believe that 2016 is coming to an end. We’ve had an amazing year at ViaCord and hope the same for you! Let’s take a quick look back at some highlights.
Duke University Medical Center is currently conducting a Phase II clinical research trial using a cord blood infusion for children with Autism Spectrum Disorder (ASD). The goal of the study is to to determine if there is a benefit from an intravenous infusion of autologous (the child’s own) or unrelated donor cord blood to children with ASD.
This clinical trial offers hope for families affected with ASD, and over a dozen ViaCord families have requested access to their banked cord blood in order to participate in the clinical research trial. Read More
Today’s guest post was written by Kate Girard, R.N. MSN and Director of Medical and Scientific Affairs here at ViaCord. Kate has been with ViaCord for 13 years. Her position entails leading the regenerative medicine team in working to identify and explore research involving new applications for cord blood and cord tissue stem cells.
I spent six years as a Labor & Delivery nurse, helping bring hundreds of babies into this beautiful and sometimes crazy world. With each birth, the wonder of it all struck me like lightening. These tiny lives – so small and innocent, yet so full of potential – will have opportunities and experiences we can’t even imagine. Read More
When Tyler and Ali Krebs decided to bank their third child’s cord blood stem cells, they did so in hoping that it could potentially be used to help Ali, who had been diagnosed with Type 1 Diabetes. They never thought that their new baby, Brady, would need to use it himself. Read More
It’s time to #TurnItGold! September is Childhood Cancer Awareness Month and just like thousands of other people this month, we want to show our support and honor the children who are fighting against childhood cancer. To do so, we are supporting the
Go Gold Fund’s initiative to “Show Your Gold” as a way to show support and help create awareness around childhood cancer. Read More